Large-scale testing (Phase 3)Study completedNCT01483560
What this trial is testing
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Who this might be right for
Diabetes Mellitus, Type 1
University of Glasgow 493
Showing 20 of 28 results